Variant report
Variant | nsv976260 |
---|---|
Chromosome Location | chr13:66894108-66899792 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-AL445989.1-13 | chr13:66897306-66897693 | ENSG00000234527.1 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs145436661 | chr13:66896427-66896428 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs552271285 | chr13:66896438-66896439 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs570962740 | chr13:66896489-66896490 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs547519853 | chr13:66896511-66896512 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs17501046 | chr13:66896512-66896513 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs539482185 | chr13:66896528-66896529 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs549531057 | chr13:66896543-66896544 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs569608789 | chr13:66896544-66896545 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs116750913 | chr13:66896552-66896553 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs555689412 | chr13:66896581-66896582 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs572316744 | chr13:66896603-66896604 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs534814472 | chr13:66896663-66896664 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs568276565 | chr13:66896675-66896676 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs190262073 | chr13:66896698-66896699 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs543871225 | chr13:66896709-66896710 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs563561923 | chr13:66896710-66896711 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs573684015 | chr13:66896769-66896770 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs535764294 | chr13:66896788-66896789 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs548043372 | chr13:66896823-66896824 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs542956411 | chr13:66896842-66896843 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs148406070 | chr13:66896854-66896855 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs528715481 | chr13:66896879-66896880 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs551695136 | chr13:66896930-66896931 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs371721368 | chr13:66896931-66896932 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs144012123 | chr13:66896941-66896942 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs566221317 | chr13:66896942-66896943 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs146453607 | chr13:66896961-66896962 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs146267144 | chr13:66896975-66896976 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs533819671 | chr13:66897008-66897009 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs535440162 | chr13:66897013-66897014 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs548951999 | chr13:66897016-66897017 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs201426033 | chr13:66897042-66897043 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs565990183 | chr13:66897044-66897045 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs267316 | chr13:66897047-66897048 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs528964728 | chr13:66897086-66897087 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs182147514 | chr13:66897131-66897132 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs113433334 | chr13:66897136-66897137 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs577746209 | chr13:66897150-66897151 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs537184765 | chr13:66897248-66897249 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs561380777 | chr13:66897267-66897268 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs565380691 | chr13:66897305-66897306 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs573747203 | chr13:66897357-66897358 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
43 | rs542617222 | chr13:66897383-66897384 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
44 | rs559285852 | chr13:66897400-66897401 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
45 | rs368827734 | chr13:66897401-66897402 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
46 | rs545660846 | chr13:66897427-66897428 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
47 | rs565371649 | chr13:66897464-66897465 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
48 | rs531123582 | chr13:66897510-66897511 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
49 | rs543198603 | chr13:66897543-66897544 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
50 | rs34868619 | chr13:66897590-66897591 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Prostate cancer | 16461572 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Schizophrenia | 23813976 | CNVD |
Prostate cancer | 22341455 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:66896400-66898600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
2 | chr13:66896400-66898800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
3 | chr13:66897200-66897400 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
4 | chr13:66897200-66898400 | Enhancers | Rectal Smooth Muscle | rectum |
5 | chr13:66898000-66898200 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
6 | chr13:66898000-66898400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
7 | chr13:66898000-66898600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
8 | chr13:66898600-66903400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
9 | chr13:66898800-66903400 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |